$NVLX (Triple) breakout candles called $0.15
PYCKtradr 1/23/14














Shares Outstanding 593,411,348 a/o Dec 13, 2013
Float Not Available







Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly
2/24/2014 9:00:00 AM - Market Wire

Move Over Celgene Here Comes Nuvilex and $27 Million to Advance Its Pancreatic Cancer Clinical Trials
2/21/2014 9:00:00 AM - Market Wire

BMRN Awaits EMA Nod, KIN Hits A High, Nuvilex Gets Rich, OHRP A Sight Better
2/20/2014 10:38:00 PM - RTT News

BMRN Awaits EMA Nod, KIN Hits A High, Nuvilex Gets Rich, OHRP A Sight Better
2/20/2014 10:38:00 PM - RTT News

Nuvilex's Pancreatic Cancer Treatment Readies to Challenge Eli Lilly and Celgene in Late-Phase Clinical Trials
2/19/2014 9:00:00 AM - Market Wire

Nuvilex (NVLX) Partner, Austrianova Chairman and Chief Technical Officer, to Present at Phacilitate International Cell & Gene Therapy Forum 2014, January 27-29 in Washington, D.C.



1/24/2014 9:30:00 AM - GlobeNewswire

Obama's Shifting Opinion Good News for Marijuana Industry and Nuvilex

1/21/2014 9:30:00 AM - Market Wire

Nuvilex and Medical Marijuana Companies Keep an Eye on Florida as Crucial Swing State in Cannabis Debate

1/16/2014 9:00:00 AM - Market Wire

Nuvilex's Medical Marijuana Sciences Prepares to Enhance Industry's Research With Cell-in-a-Box(TM)

1/14/2014 9:30:00 AM - Market Wire

Nuvilex Growing Medical Marijuana Sciences to Lead Marijuana Research Industry

1/9/2014 9:30:00 AM - Market Wire